Currently, the only proven treatment to re-establish cerebral blood flow in acute ischemic stroke is intravenous tissue plasminogen activator within 3 h of symptom onset. Few patients, however, qualify for this therapy. Here, Juttler et al. provide an integrated view of the current state of reperfusion therapy in acute stroke patients and discuss future treatment options to extend the therapeutic window for intervention.
- Eric Juttler
- Martin Kohrmann
- Peter D Schellinger